Cargando…
Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates
The use of antibody-drug conjugates (ADCs) as a therapeutic platform to treat cancer has recently gained substantial momentum. This therapeutic modality has the potential to increase the efficacy and reduce the systemic toxicity associated with current therapeutic regimens. The efficacy of ADCs, how...
Autores principales: | Ritchie, Michael, Tchistiakova, Lioudmila, Scott, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564878/ https://www.ncbi.nlm.nih.gov/pubmed/23221464 http://dx.doi.org/10.4161/mabs.22854 |
Ejemplares similares
-
Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates
por: Kalim, Muhammad, et al.
Publicado: (2017) -
Synchronous intracellular delivery of EGFR-targeted antibody–drug conjugates by p38-mediated non-canonical endocytosis
por: Takahashi, Jun-ichiro, et al.
Publicado: (2022) -
Necrotic cell death and neurodegeneration: The involvement of endocytosis and intracellular trafficking
por: Troulinaki, Kostoula, et al.
Publicado: (2012) -
Intracellular Trafficking Network of Protein Nanocapsules: Endocytosis, Exocytosis and Autophagy
por: Zhang, Jinxie, et al.
Publicado: (2016) -
Intracellular Trafficking Pathways of Edwardsiella tarda: From Clathrin- and Caveolin-Mediated Endocytosis to Endosome and Lysosome
por: Sui, Zhi-hai, et al.
Publicado: (2017)